Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Nephrol Dial Transplant
    September 2021
  1. FAIVRE A, Scholz CC, de Seigneux S
    Hypoxia in chronic kidney disease: towards a paradigm shift?
    Nephrol Dial Transplant. 2021;36:1782-1790.
    >> Share

    July 2021
  2. BESARAB A, Drueke TB
    The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.
    Nephrol Dial Transplant. 2021;36:1377-1383.
    >> Share

  3. LOCATELLI F, Del Vecchio L, De Nicola L, Minutolo R, et al
    Are all erythropoiesis-stimulating agents created equal?
    Nephrol Dial Transplant. 2021;36:1369-1377.
    >> Share

    June 2021
  4. BARRATT J, Andric B, Tataradze A, Schomig M, et al
    Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a phase 3, randomised, open-label, active-controlled study (DOLOMITES).
    Nephrol Dial Transplant. 2021 Jun 2. pii: 6291250. doi: 10.1093.
    >> Share

    May 2021
  5. LOCATELLI F, Del Vecchio L
    A new paradigm in treating patients with chronic kidney disease and anaemia after a journey lasting more than 35 years.
    Nephrol Dial Transplant. 2021 May 20. pii: 6278901. doi: 10.1093.
    >> Share

  6. AYERDEM G, van Hassel G, Vinke JSJ, Kremer DJ, et al
    Iron deficiency, with and without anemia, across strata of kidney function in kidney transplant recipients.
    Nephrol Dial Transplant. 2021 May 3. pii: 6263840. doi: 10.1093.
    >> Share

    March 2021
  7. SINGH AK, Blackorby A, Cizman B, Carroll K, et al
    Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2021 Mar 21. pii: 6179323. doi: 10.1093.
    >> Share

    February 2021
  8. NANGAKU M, Kondo K, Ueta K, Kokado Y, et al
    Efficacy and safety of vadadustat compared with darbepoetin alfa in japanese anemic patients on hemodialysis: A phase 3, multicenter, randomized, double-blind study.
    Nephrol Dial Transplant. 2021 Feb 26. pii: 6154307. doi: 10.1093.
    >> Share

  9. SHUTOV E, Sulowicz W, Esposito C, Tataradze A, et al
    Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, double-blind, placebo-controlled study (ALPS).
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149483. doi: 10.1093.
    >> Share

  10. PROVENZANO R, Shutov E, Eremeeva L, Korneyeva S, et al
    Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149078. doi: 10.1093.
    >> Share

  11. GUEDES M, Muenz D, Zee J, Lopes MB, et al
    Serum biomarkers of iron stores are associated with worse physical health-related quality of life (HRQoL) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with or without anemia.
    Nephrol Dial Transplant. 2021 Feb 24. pii: 6149131. doi: 10.1093.
    >> Share

  12. GOTTA V, Tancev G, Marsenic O, Vogt JE, et al
    Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.
    Nephrol Dial Transplant. 2021;36:519-528.
    >> Share

    January 2021
  13. HODSON EM, Strippoli GFM
    Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation.
    Nephrol Dial Transplant. 2021;36:205-207.
    >> Share

    December 2020
  14. MONET-DIDAILLER C, Chevallier A, Godron-Dubrasquet A, Allard L, et al
    Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Nephrol Dial Transplant. 2020;35:2147-2153.
    >> Share

    November 2020
  15. ECKARDT KU, Agarwal R, Farag YM, Jardine AG, et al
    Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
    Nephrol Dial Transplant. 2020 Nov 14. pii: 5981973. doi: 10.1093.
    >> Share

    October 2020
  16. ZHENG Q, Yang H, Fu X, Huang Y, et al
    The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2020 Oct 14. pii: 5923003. doi: 10.1093.
    >> Share

    August 2020
  17. MINUTOLO R, Garofalo C, Chiodini P, Aucella F, et al
    Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2020 Aug 23. pii: 5896177. doi: 10.1093.
    >> Share

    July 2020
  18. NANGAKU M, Farag YMK, deGoma E, Luo W, et al
    Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients.
    Nephrol Dial Transplant. 2020 Jul 28. pii: 5877009. doi: 10.1093.
    >> Share

    June 2020
  19. FLOEGE J, Funk F, Ketteler M, Rastogi A, et al
    Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
    Nephrol Dial Transplant. 2020;35:946-954.
    >> Share

    February 2020
  20. BHANDARI S, Kalra PA, Berkowitz M, Belo D, et al
    Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Nephrol Dial Transplant. 2020 Feb 12. pii: 5734687. doi: 10.1093.
    >> Share

  21. GACKLER A, Kaulfuss M, Rohn H, Vogel U, et al
    Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab.
    Nephrol Dial Transplant. 2020;35:298-303.
    >> Share

    October 2019
  22. AWAN AA, Walther CP, Richardson PA, Shah M, et al
    Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
    Nephrol Dial Transplant. 2019 Oct 22. pii: 5602623. doi: 10.1093.
    >> Share

    May 2019
  23. VILLAIN C, Ecochard R, Bouchet JL, Daugas E, et al
    Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients.
    Nephrol Dial Transplant. 2019;34:848-858.
    >> Share

    March 2019
  24. LOCATELLI F, Del Vecchio L
    Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?
    Nephrol Dial Transplant. 2019 Mar 7. pii: 5371147. doi: 10.1093.
    >> Share

  25. SCHAPIRO D, Daga A, Lawson JA, Majmundar AJ, et al
    Panel sequencing distinguishes monogenic forms of nephritis from nephrosis in children.
    Nephrol Dial Transplant. 2019;34:474-485.
    >> Share

    December 2018
  26. TSUJITA M, Kosugi T, Goto N, Futamura K, et al
    The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial.
    Nephrol Dial Transplant. 2018 Dec 17. pii: 5250855. doi: 10.1093.
    >> Share

    October 2018
  27. BLOCK GA, Pergola PE, Fishbane S, Martins JG, et al
    Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
    Nephrol Dial Transplant. 2018 Oct 30. pii: 5149799. doi: 10.1093.
    >> Share

    July 2018
  28. MIN HK, Sung SA, Oh YK, Kim YH, et al
    Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2018 Jul 23. pii: 5057655. doi: 10.1093.
    >> Share

  29. KARABOYAS A, Morgenstern H, Pisoni RL, Zee J, et al
    Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.
    Nephrol Dial Transplant. 2018 Jul 11. pii: 5052242. doi: 10.1093.
    >> Share

    April 2018
  30. HAASE VH, Chertow GM, Block GA, Pergola PE, et al
    Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.
    Nephrol Dial Transplant. 2018 Apr 16. pii: 4973359. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016